Mitochondrial superoxide: a key player in Alzheimer's disease - PubMed (original) (raw)

Mitochondrial superoxide: a key player in Alzheimer's disease

Cynthia A Massaad et al. Aging (Albany NY). 2009.

No abstract available

Keywords: Alzheimer's disease; Mitochondria; Oxidative Stress; SOD-2; Tg2576.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Similar articles

• Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease.
  Massaad CA, Washington TM, Pautler RG, Klann E. Massaad CA, et al. Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13576-81. doi: 10.1073/pnas.0902714106. Epub 2009 Aug 3. Proc Natl Acad Sci U S A. 2009. PMID: 19666610 Free PMC article.
• SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.
  Murakami K, Murata N, Noda Y, Tahara S, Kaneko T, Kinoshita N, Hatsuta H, Murayama S, Barnham KJ, Irie K, Shirasawa T, Shimizu T. Murakami K, et al. J Biol Chem. 2011 Dec 30;286(52):44557-68. doi: 10.1074/jbc.M111.279208. Epub 2011 Nov 9. J Biol Chem. 2011. PMID: 22072713 Free PMC article.
• Evaluation of Mitochondrial Oxidative Stress in the Brain of a Transgenic Mouse Model of Alzheimer's Disease by in vitro Electron Paramagnetic Resonance Spectroscopy.
  Manabe T, Matsumura A, Yokokawa K, Saito T, Fujikura M, Iwahara N, Matsushita T, Suzuki S, Hisahara S, Kawamata J, Suzuki H, Emoto MC, Fujii HG, Shimohama S. Manabe T, et al. J Alzheimers Dis. 2019;67(3):1079-1087. doi: 10.3233/JAD-180985. J Alzheimers Dis. 2019. PMID: 30714961
• Mitochondrial Pharmaceutics: A New Therapeutic Strategy to Ameliorate Oxidative Stress in Alzheimer's Disease.
  Ajith TA, Padmajanair G. Ajith TA, et al. Curr Aging Sci. 2015;8(3):235-40. doi: 10.2174/187460980803151027115147. Curr Aging Sci. 2015. PMID: 25986626 Review.
• Mitochondrial amyloid-beta peptide: pathogenesis or late-phase development?
  Yan SD, Xiong WC, Stern DM. Yan SD, et al. J Alzheimers Dis. 2006 Jul;9(2):127-37. doi: 10.3233/jad-2006-9205. J Alzheimers Dis. 2006. PMID: 16873960 Review.

Cited by

• Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases.
  Korczowska-Łącka I, Słowikowski B, Piekut T, Hurła M, Banaszek N, Szymanowicz O, Jagodziński PP, Kozubski W, Permoda-Pachuta A, Dorszewska J. Korczowska-Łącka I, et al. Antioxidants (Basel). 2023 Sep 29;12(10):1811. doi: 10.3390/antiox12101811. Antioxidants (Basel). 2023. PMID: 37891890 Free PMC article. Review.
• An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease.
  Lanza M, Basilotta R, Cuzzocrea S, Bulzomì M, Oddo S, Casili G, Esposito E. Lanza M, et al. Int J Mol Sci. 2023 Jul 11;24(14):11303. doi: 10.3390/ijms241411303. Int J Mol Sci. 2023. PMID: 37511065 Free PMC article.
• Microfluidic/HPLC combination to study carnosine protective activity on challenged human microglia: Focus on oxidative stress and energy metabolism.
  Privitera A, Cardaci V, Weerasekara D, Saab MW, Diolosà L, Fidilio A, Jolivet RB, Lazzarino G, Amorini AM, Camarda M, Lunte SM, Caraci F, Caruso G. Privitera A, et al. Front Pharmacol. 2023 Mar 29;14:1161794. doi: 10.3389/fphar.2023.1161794. eCollection 2023. Front Pharmacol. 2023. PMID: 37063279 Free PMC article.
• 3-Bromopyruvate, a caloric restriction mimetic, exerts a mitohormetic effect to provide neuroprotection through activation of autophagy in rats during aging.
  Arya JK, Kumar R, Tripathi SS, Rizvi SI. Arya JK, et al. Biogerontology. 2022 Oct;23(5):641-652. doi: 10.1007/s10522-022-09988-5. Epub 2022 Sep 1. Biogerontology. 2022. PMID: 36048311
• The Hidden Notes of Redox Balance in Neurodegenerative Diseases.
  Piccirillo S, Magi S, Preziuso A, Serfilippi T, Cerqueni G, Orciani M, Amoroso S, Lariccia V. Piccirillo S, et al. Antioxidants (Basel). 2022 Jul 26;11(8):1456. doi: 10.3390/antiox11081456. Antioxidants (Basel). 2022. PMID: 35892658 Free PMC article. Review.

References

1. 1. Massaad CA, Washington TM, Pautler RG, Klann E. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2009;106:13576–13581. - PMC - PubMed
2. 1. Tanzi R, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 2005;120:545–555. - PubMed
3. 1. Yankner B, Dawes L, Fisher S. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 1989;245:417–420. - PubMed
4. 1. Cadenas E. Mitochondrial free radical production and cell signaling. Mol Aspects Med. 2004;25:17–26. - PubMed
5. 1. Butterfield D, Griffin S, Munch G, Pasinetti G. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis. 2002;4:193–201. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

• T32 HL07676/HL/NHLBI NIH HHS/United States
• R01 AG029977/AG/NIA NIH HHS/United States
• R01 NS047384/NS/NINDS NIH HHS/United States
• NS047384/NS/NINDS NIH HHS/United States
• R37 NS034007/NS/NINDS NIH HHS/United States
• R29 NS034007/NS/NINDS NIH HHS/United States
• AG029977/AG/NIA NIH HHS/United States
• NS034007/NS/NINDS NIH HHS/United States
• R01 NS034007/NS/NINDS NIH HHS/United States
• T32 HL007676/HL/NHLBI NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information